- Home
- HROW vs GAM Comparison
HROW vs GAM Comparison
Compare HROW & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- GAM
- Stock Information
- Founded
- HROW 1998
- GAM 1927
- Country
- HROW United States
- GAM United States
- Employees
- HROW 382
- GAM N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- GAM Investment Managers
- Sector
- HROW Health Care
- GAM Finance
- Exchange
- HROW Nasdaq
- GAM Nasdaq
- Market Cap
- HROW 1.4B
- GAM 1.4B
- IPO Year
- HROW N/A
- GAM N/A
- Fundamental
- Price
- HROW $39.22
- GAM $59.58
- Analyst Decision
- HROW Strong Buy
- GAM
- Analyst Count
- HROW 7
- GAM 0
- Target Price
- HROW $64.67
- GAM N/A
- AVG Volume (30 Days)
- HROW 671.7K
- GAM 20.1K
- Earning Date
- HROW 08-11-2025
- GAM 01-01-0001
- Dividend Yield
- HROW N/A
- GAM 5.74%
- EPS Growth
- HROW N/A
- GAM N/A
- EPS
- HROW N/A
- GAM 11.67
- Revenue
- HROW $227,661,000.00
- GAM N/A
- Revenue This Year
- HROW $46.17
- GAM N/A
- Revenue Next Year
- HROW $39.97
- GAM N/A
- P/E Ratio
- HROW N/A
- GAM $3.95
- Revenue Growth
- HROW 47.69
- GAM N/A
- 52 Week Low
- HROW $20.85
- GAM $37.32
- 52 Week High
- HROW $59.23
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- HROW 62.35
- GAM 68.05
- Support Level
- HROW $37.09
- GAM $58.74
- Resistance Level
- HROW $39.67
- GAM $60.51
- Average True Range (ATR)
- HROW 2.41
- GAM 0.68
- MACD
- HROW 0.10
- GAM 0.03
- Stochastic Oscillator
- HROW 87.23
- GAM 68.58
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.